Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Drugs to treat asthma Can you drink alcohol while taking Ozempic for weight loss
What's in it
Our brand visibility and doctor connect programs help you gain trust in the market
Key Points Summary Asias GLP1 uptake has lagged the West but is primed for rapid acceleration as obesity rates rise and government urgency grows China and India are driving demand shifts as diets westernise and metabolic disease climbs Cost barriers are falling: local firms in China and India are developing cheaper semaglutide generics, forcing price cuts Mintel forecasts explosive growth, with China potentially becoming the worlds No1 GLP1 market by 2030 Safety fears persist in China (side effects, rebound, semaglutide face) and in India (strict rules on drug promotion) GLP-1 agonist drugs have revolutionised weight loss in the United States and parts of Europe, providing in most cases a highly effective way to manage the ballooning issue of obesity in these markets
Membrane and bead amounts were as follows: hGLP-1R (0.35 g protein, 0.125 mg bead), mGLP-1R (0.25 g protein, 0.125 mg bead), hGIPR (6 g protein, 0.2 mg bead) and mGIPR (7 g protein, 0.25 mg bead)
US$ 28.27
US$ 20.13
US$ 25.97
US$ 25.73
